Resona Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$40.2M Sell
664,074
-5,292
-0.8% -$308K 0.2% 100
2025
Q4
$36.1M Sell
669,366
-21,761
-3% -$1.05M 0.17% 105
2025
Q3
$31.1M Sell
691,127
-46,004
-6% -$2.15M 0.15% 130
2025
Q2
$34.1M Buy
737,131
+42,772
+6% +$2.1M 0.17% 119
2025
Q1
$42.2M Buy
694,359
+38,040
+6% +$2.22M 0.24% 88
2024
Q4
$37.2M Sell
656,319
-38,360
-6% -$2.14M 0.22% 86
2024
Q3
$35.9M Sell
694,679
-9,678
-1% -$454K 0.21% 97
2024
Q2
$29.3M Sell
704,357
-71,209
-9% -$3.19M 0.18% 113
2024
Q1
$42.1M Buy
+775,566
New +$39.5M 0.25% 83

Other funds holding BMY

Resona Asset Management's BMY Position: Q1 2026 in Review

Resona Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 0.79% in Q1 2026, selling an estimated $308K and leaving 664,074 shares worth $40.2M. The position accounts for 0.2% of the portfolio, ranked #100.

Resona Asset Management first reported a position in BMY in Q1 2024 and has held it in 9 quarters since. The position peaked at $42.2M in Q1 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Resona Asset Management held 664,074 shares of Bristol-Myers Squibb worth $40.2M as of Q1 2026.
  • Resona Asset Management sold 5,292 Bristol-Myers Squibb shares in Q1 2026, an estimated $308K.
  • Bristol-Myers Squibb made up 0.2% of Resona Asset Management's portfolio in Q1 2026, its #100 holding.
  • Resona Asset Management first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 9 quarters since.
  • Resona Asset Management's Bristol-Myers Squibb position peaked at $42.2M in Q1 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Resona Asset Management's 13F filing for Q1 2026, filed 30 Apr 2026.